Latest total revenue for NMRD: $-1.6M, below the Healthcare sector average of $540B.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2023
Trailing 12 months ending Dec 2023
The latest total revenue for NMRD is $-1.6M as of December 2023. That compares with $400K in the prior-year period — down 491.0% year over year. That is below the Healthcare sector average of $540B. Investors often review this figure alongside Nemaura Medical's historical trend and sector peers before judging valuation or financial health.
Over the past year, NMRD's total revenue moved from $400K to $-1.6M — a 491.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nemaura Medical's operating scale or balance-sheet position.
Against Healthcare companies, NMRD currently prints $-1.6M for total revenue, while the sector average sits near $540B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nemaura Medical's growth, margins, and balance sheet.
A total revenue figure of $-1.6M for NMRD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $540B. Explore the charts below for those layers of context.
After noting NMRD's total revenue ($-1.6M), review year-over-year change from $400K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.